VisionGate, Inc. Employee Directory
Biotechnology ResearchArizona, United States11-50 Employees
VisionGate, Inc. is a biotechnology research company focused on developing early-detection solutions for lung cancer using a non-invasive sputum test. Its core technology, the Cell-CT 3-Dimensional Cell Imaging platform, creates three-dimensional images of individual cells and can recognize more than 700 biomarkers, enabling analysis of liquid biopsy specimens with potential applicability to other cancers. The lead diagnostic product is LuCED, a sputum-based test designed to detect abnormal cells linked to lung cancer and bronchial dysplasia, and to assess indeterminate pulmonary nodules. LuCED relies on the Cell-CT platform, and VisionGate is developing CellGazer, imaging software intended to support cytopathology diagnosis of detected cells. The company is based in Phoenix, Arizona, and operates with a small team; in November 2023 it appointed Neil Bush to its Board of Directors.